Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Five Period, Crossover, Study to Evaluate the Effects of Single Doses of MK4305 on Polysomnogram (PSG) in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Aug 2013
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications Insomnia
- Focus Pharmacodynamics
- Sponsors Merck & Co
- 16 Aug 2013 New trial record